Sudocrem

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sudocrem

Property Description
Active Ingredient Zinc Oxide
Form Emulsified Water-in-Oil Cream
Pharmacological Class Barrier Protectant, Mild Astringent
OTC Status Over-the-Counter (OTC)
Manufacturer Origin Ireland

Sudocrem Antiseptic Healing Cream is a widely recognized, over-the-counter (OTC) topical preparation primarily classified as a skin barrier protectant and mild antiseptic. Developed in Dublin, Ireland, in 1931, it is a multi-purpose product that has established itself as a common staple in baby and family care.

The cream's core function is based on its primary active ingredient, Zinc Oxide (15.29%), which is a widely studied dermatological agent. Zinc Oxide is known to form a protective, water-repellent barrier over the skin. This barrier is crucial for protecting the skin from external irritants like moisture and bodily fluids, a necessary action in the management and prevention of irritant contact dermatitis, such as nappy rash.

A key differentiating aspect of Sudocrem is its complex composition. Beyond the barrier protection offered by Zinc Oxide, the formulation includes several other compounds:

  • Anhydrous Hypoallergenic Lanolin acts as an emollient to soothe and soften the skin, helping to maintain natural moisture.
  • Benzyl Alcohol provides mild local anesthetic properties, which helps ease the discomfort and pain associated with skin irritation, and also possesses antiseptic qualities.

This blend of protective, emollient, and mild antiseptic components provides a comprehensive approach to managing common, mild skin irritations. While most commonly associated with nappy rash, its properties indicate its use for general surface wound care, minor abrasions, and other barrier-related skin issues.

What side effects are possible with Sudocrem?

Possible Side Effects and Safety Information

This section describes the adverse reactions and high-level safety constraints documented in official government regulatory documents for this product.


Official Adverse Reaction Profile

Side effects are primarily classified within the Skin and Subcutaneous Tissue Disorders organ system. The most commonly documented reaction formally categorized by frequency is Local Hypersensitivity (an allergic reaction), which is classified as occurring Occasionally in regulatory texts. The potential for general local irritation is also noted in safety documentation.

System-Organ Class Specific Reactions/Effects
Skin and Subcutaneous Tissue Disorders Local hypersensitivity reaction, Local irritation
Gastrointestinal Disorders Vomiting, Diarrhea (associated with accidental ingestion)
Nervous System Disorders CNS stimulation, Convulsions (associated with accidental ingestion)

Serious adverse reactions, specifically CNS stimulation and convulsions, are documented as potential consequences of accidental ingestion of large quantities of the cream and are not risks associated with standard topical use.


Population-Specific Notes and Safety Constraints

Safety documents include explicit warnings for specific groups. For Newborn Babies (up to 4 weeks old), an excipient, Sodium Benzoate, may cause local irritation and potentially increase the risk of jaundice.

Use of the product is formally contraindicated in individuals with known hypersensitivity to any of its components. Furthermore, official labeling includes a mandatory high-level safety constraint: materials such as clothing or bedding that have been in contact with the product are noted to be a serious fire hazard as they may burn more easily.

Overdose and Emergency Response

Overdose and When to Seek Help

The regulatory overdose profile for this topical cream is exclusively structured around the potential risks associated with accidental oral ingestion of the product, as opposed to application errors or excessive topical use. The official documentation notes that no cases of overdose have been reported in clinical experience.

Feature Regulatory Documentation Statement
Documented Clinical Manifestations Vomiting, diarrhoea, and CNS stimulation are documented if large amounts of the cream are swallowed accidentally.
Severe Outcomes Potential for severe neurological effects, including convulsions, is stated in the labeling following accidental ingestion of substantial quantities.
Officially Described Treatment Symptomatic and supportive treatment should be provided for the management of toxicity.
Antidote Information No specific antidote is documented in the product's official prescribing information.

When Immediate Medical Help is Required

The official labeling explicitly mandates urgent action in the event of accidental ingestion. If this product is swallowed, individuals must seek immediate medical attention and contact a Poison Control Center immediately to manage the potential for systemic toxicity. This requirement applies because symptoms are related to the dose-dependent risk of accidental swallowing of large quantities, which may affect the Central Nervous System. Treatment, as officially described in the regulatory documents, is limited to supportive care for the observed clinical manifestations.

Therapeutic Uses of Sudocrem

What Sudocrem Treats: Main Uses and Benefits

Sudocrem is commonly used across therapeutic domains where localized skin symptoms create discomfort or temporary functional strain, offering symptomatic relief and protective support. The cream's primary role is consistent with supportive symptom management, particularly involving protection against wetness and irritation, and is considered relevant for supportive symptom management. This therapeutic focus is consistent with the product's classification.

It helps address symptom clusters related to skin irritation, inflammation, and soreness. The product is generally used for conditions presenting with acute episodes, including nappy rash, minor cuts and grazes, abrasions, mild eczema, sunburn, and acne. It provides supportive relief that helps ease the overall symptom burden, contributing to easing the intense discomfort and pain associated with skin breakdown.


Quick Fact: Relief for Irritated Skin

Sudocrem is applied in scenarios where additional management of discomfort is required, supporting patients during challenging symptomatic phases. It is relevant for managing symptoms that interfere with daily comfort during periods of localized inflammation and redness.

Regulatory References

  1. NIH DailyMed official drug label for SUDOCREM

Eligibility and Restrictions for Use

Official Eligibility for Sudocrem Use

The official regulatory profile for Sudocrem, a topical skin protectant, broadly permits its use across the entire population, with restrictions primarily related to the presence of allergies or the condition of the skin surface.

Eligibility Scope

Category Official Regulatory Status
Contraindicated Populations Individuals with known hypersensitivity to the active substance, Zinc Oxide, or any excipient (such as Lanolin or Benzyl Alcohol).
Age-Group Eligibility Use is established and permitted for all ages, including infants, children, adults, and older adults. No age distinction is required for general use.
Pregnancy and Lactation Use is permitted during both pregnancy and breastfeeding, as systemic absorption following topical application is negligible.
Comorbidity Limitations None explicitly documented for conditions like hepatic or renal impairment due to the drug's localized action.
Eligibility-Related Restrictions The product is for external use only and must not contact the eyes or mucous membranes. It is not recommended for application to broken skin, large open wounds, or severe skin injuries.

The single absolute non-eligibility rule defined by regulators is the risk of an allergic response to any of the product’s components, which necessitates a strict contraindication for hypersensitive individuals. The absence of systemic restrictions, such as those concerning renal or hepatic impairment, reinforces the medicine’s classification as a low-risk, localized topical treatment established for use across the lifespan.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Sudocrem Antiseptic Healing Cream is defined by the absence of documented interaction patterns with other medicines, food, or substances. Governmental regulatory documentation, such as the Summary of Product Characteristics (SmPC), explicitly states that no formal interaction studies have been performed for this product.

Consequently, the authoritative label for interactions with other medicinal products formally concludes: "None known."

This documented absence of findings results in an interaction section that lists no specific interacting substances or medicinal product classes. The profile contains no information regarding mechanistic effects, such as alterations to drug metabolism or clearance, nor are any pharmacodynamic additive effects officially described. The product’s regulatory status establishes that there are no formal prohibitions, mandatory timing rules, or restrictions regarding co-administration with other medicines or supplements based on interaction risk.

No contraindicated combinations are listed, and no specific population-dependent interaction considerations are documented in the official prescribing information. The overall interaction structure of the product is therefore summarized by this transparent statement that the interaction potential has not been formally established through regulatory studies, and no constraints are mandated in the interaction section of the official label.

Mechanism of Action

The formulation's mechanism of action is multifaceted, involving physical barrier function and molecular interaction. Zinc Oxide creates a high-density, physical layer upon the stratum corneum. This layer forms an occlusive structure that mechanically impedes the passage of external fluids and irritants to the underlying dermal tissue, altering the local microenvironment. Lanolin, an emollient, acts by interacting with lipids within the intercellular matrix of the epidermis, specifically modulating transepidermal water loss (TEWL). This influences the local hydration state of the tissue. Benzyl Alcohol demonstrates local molecular effects by influencing cellular membrane permeability in a concentration-dependent manner. Benzyl Benzoate functions primarily as an intermediate solvent, impacting the overall partitioning and biological availability of the other components within the topical vehicle. These ingredients' physicochemical interactions within the formulation further govern the specific bioavailability and distribution of each component, dictating the ultimate system-level physiological modulation.

Dosage and Administration Information

How to Use Sudocrem

The usage protocol for Sudocrem Antiseptic Healing Cream focuses on topical administration technique and frequency rather than specific dosage amounts.

Official Administration Guidelines

Sudocrem is formulated as a cream for topical use only and must be applied externally to the skin. The administration instructions are identical for all age groups; no distinction is required between adults, children, and the elderly.

Field Official Instruction
Route of Administration Topical (External use only).
Dosing Schedule Apply a thin layer or apply liberally.
Frequency Pattern As required; renew application as required.
Prior Preparation The skin area should be cleansed and allowed to dry before application.

Procedural Steps for Use

A specific technique is utilized to ensure proper coverage and effectiveness. For optimal application:

  1. Ensure the affected skin area is clean and dry.
  2. Apply a small amount of cream to the area.
  3. Gently massage the cream into the affected area in circular movements.
  4. The correct amount has been applied when a thin, translucent film remains on the skin, avoiding a thick, white coating.
  5. Renew application as necessary, such as during each diaper change for infants.

This application technique establishes a standardized approach to using the cream, defining how the topical form should be correctly handled and applied for its intended purpose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sudocrem

Research Evidence for Infantile Nappy Rash (Diaper Dermatitis)

Research exploring Sudocrem was studied for use in infantile nappy rash and has included older Randomized Controlled Trials (RCTs) and larger-scale Real-World Evidence (RWE) Retrospective Studies. Studies were applied in research contexts involving fluctuating or unstable symptoms and research examined outcomes such as the resolution of the rash, as well as objective and patient-reported outcomes describing perceived discomfort. The primary populations studied were infants and children up to approximately three years old who presented with slight to moderate rash severity. The follow-up durations were limited in many prospective trials, and comparative evidence is lacking against the full range of modern preparations.

Research Evidence for Adult Incontinence-Associated Dermatitis (IAD)

The evidence base for use in adults, specifically for Incontinence-Associated Dermatitis (IAD), was evaluated in older Randomized Controlled Trials (RCTs) and comparative trials. The research examined outcomes linked to inflammatory or irritative states and explored the potential for application in the treatment and prevention (prophylaxis) of the condition. The core evidence relies on legacy data from older trials, and the studies focused on narrow populations, typically geriatric patients. There is a lack of recent, large-scale comparative research to contextualize the findings against contemporary advanced barrier products.

Evidence Supporting General Skin Barrier Function

Research for the product's fundamental properties is structured around basic pharmacological research on the active ingredient, Zinc Oxide, supported by regulatory assessment documentation. This research examined the formation of a barrier-forming, water-repellent film and monitored the inherent mild astringent effects. Regulatory evaluations and laboratory research provide context for understanding the known physical effects associated with physiological strain or stress. The evidence for generalized uses is largely based on research exploring the established physical barrier and astringent functions of the active ingredients, rather than dedicated clinical trials.

Frequently Asked Questions (FAQ)

Common questions about Sudocrem (FAQ)

Q: What is the difference between Sudocrem and standard moisturizing creams?

Official product information indicates that Sudocrem is classified as a barrier protectant. The formulation contains functional components like Zinc Oxide, which forms a protective layer, and Benzyl Alcohol, which is known to possess mild local anesthetic properties. These functional ingredients differentiate the cream from those intended for basic skin moisture retention alone.

Q: Is it safe to use Sudocrem on highly sensitive or delicate skin areas?

According to regulatory documentation, the Lanolin included in the formulation is a hypoallergenic grade, meaning the Lanolin component is processed to help reduce the potential for allergic sensitization. However, the product is formally contraindicated if a person has a known hypersensitivity or allergy to any of its components.

Q: Are there any known adverse effects if too thick a layer of Sudocrem is applied?

Official application guidance emphasizes applying a thin layer of the cream, ensuring it leaves a translucent, non-white film on the skin. Official usage protocols describe applying a thin layer, which suggests that avoiding excessive application is preferred; however, regulatory documents do not list specific adverse effects directly caused by applying too thick a layer.

Q: Does Sudocrem interact negatively with common skincare products or ingredients?

Official regulatory documents indicate that formal interaction studies, including those with other substances and products, have not been performed for Sudocrem. Consequently, the product information states that no known interactions are listed with other medicinal products or substances.

Q: What is the recommended action if Sudocrem accidentally comes into contact with the eyes?

Official product warnings clearly state that the cream is for external, topical use only and should not contact the eyes. Official warnings state to avoid eye contact. Should contact occur, the standard safety instruction is to rinse the eyes thoroughly with water.

Q: What is the general difference between Sudocrem and a simple zinc cream?

Sudocrem contains the active ingredient Zinc Oxide, but its formula also includes other functional components. These include Lanolin, an emollient that softens the skin, and Benzyl Alcohol, which is associated with properties that can help soothe discomfort.

Q: Can Sudocrem be used alongside other topical, non-medicinal barrier creams?

Official regulatory documentation states that no formal interaction studies have been conducted for Sudocrem with other products. Based on this, the official product profile concludes that no interactions are known with other medicinal products or substances.

Q: Does Sudocrem have a defined expiration date that users should follow?

The product does have a defined shelf life. The official regulatory shelf life is typically three years from the date of manufacture for products sold in a polypropylene jar.

Q: Does the manufacturer classify Sudocrem as hypoallergenic?

The official list of ingredients and formulation profile specifies that the Lanolin included in the cream is of a hypoallergenic grade. This indicates it is processed to reduce the potential for allergic sensitization.

Q: Have there been any notable changes to the main ingredients of Sudocrem over time?

Information related to the product's regulatory history, official claims state that the core formula of Sudocrem Antiseptic Healing Cream has remained unchanged since its initial development in Dublin in 1931.

Q: What is the difference between the standard tub of Sudocrem and other product variations (e.g., small tubes)?

Regulatory information pertains to a single medicinal product, Sudocrem Antiseptic Healing Cream. The different presentations, such as tubs and tubes, are merely variations in packaging size. Any product with a different name or specific formulation is treated as a separate medicinal product with its own regulatory profile.

Q: Does Sudocrem have a distinct or recognizable scent?

The official product description found in regulatory documentation notes that the cream is described as having a lavender odour. This scent is due to the inclusion of lavender fragrance in the cream's excipients.

How should Sudocrem be stored and disposed of?

Storage and Disposal of Sudocrem

Official regulatory labeling dictates the specific conditions for storing and disposing of Sudocrem.

Storage Requirements

Sudocrem Skin Protectant Cream must be stored at room temperature, within the specific range of 15 C to 30 C (59 F to 86 F). A mandatory safety requirement is to always keep the product out of reach of children.

Disposal Instructions

Disposal of any unused or expired Sudocrem must comply with local and national regulations. If specific instructions are not provided on the label, unused product should be mixed with an undesirable substance, such as coffee grounds, and placed in a sealed container before being thrown into the household trash, following established regulatory guidance for non-hazardous medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sudocrem found in:

A-Z Index: